.png){kind=icon}
.png){kind=icon}
Return
AbrB knockout not positively affecting bacillomycin D production in Bacillus amyloliquefaciens fmbJ analyzed by metabolomics
.png){kind=icon}
PRE
AI
J
S
Y
X
庞
李
C
L
DOI：10.1016/j.jbiotec.2026.03.022.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Bacillomycin D (BD) is a potent lipopeptide with broad application potential encoded by bmyDABC with amino acids as substrates. To clarify the influence of transcriptional repressor AbrB regulating the synthesis of BD, abrB gene in Bacillus amyloliquefaciens fmbJ was successfully deleted by marker free method. Compared with the wildtype strain, BD production initially increased and then decreased. Expression of BD synthesis genes (bmyA-D) and signaling genes (spo0A, spo0B, and spo0E) all showed a brief rise in the early stage and a collective decline in the later stage, with sustained depletion of precursor amino acids (Tyr, Pro, Glu, Thr) after 36 h. EMSA and DNase I footprinting demonstrated that AbrB does not directly bind BD regulatory regions, while metabolomics revealed the exhaustion of fatty acid and amino acid precursors. These results showed that abrB knockout does not positively affecting BD production, providing guidance for more effective engineering of BD overproducing strains.
Keywords:
AbrB
Bacillomycin D
Biosynthesis
Knock out
Metabolomic
Journal
IF:
3.9
Papers:
1.5W
Citations:
1.5W
Organization
Cited Papers